Literature DB >> 326664

Oral toxicities of Clostridium botulinum toxins in response to molecular size.

I Ohishi, S Sugii, G Sakaguchi.   

Abstract

Clostridium botulinum type A, B, and F toxins of different molecular sizes were fed to mice to compare the oral toxicities. The progenitor toxin, a complex of a toxic and nontoxic component, of any type was higher in oral toxicity to mice than the dissociated toxic component or the derivative toxin. The former may no doubt play a more important role in the pathogenesis of food-borne botulism. The higher oral toxicity possessed by the progenitor toxin, including the exceptionally high one found with type B-L toxin, can be explained solely by the protection afforded by the nontoxic component attached to the toxic component. The possibility of the highest oral toxicity of type B-L toxin to humans is discussed.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 326664      PMCID: PMC421495          DOI: 10.1128/iai.16.1.107-109.1977

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  16 in total

1.  Type E botulism due to salmon eggs.

Authors:  C E DOLMAN; G E DARBY; R F LANE
Journal:  Can J Public Health       Date:  1955-04

2.  Studies on immunity to toxins of Clostridium botulinum. I. A simplified procedure for isolation of type A toxin.

Authors:  J T DUFF; G G WRIGHT; J KLERER; D E MOORE; R H BIBLER
Journal:  J Bacteriol       Date:  1957-01       Impact factor: 3.490

3.  Activation of Clostridium botulinum type E toxin by trypsin.

Authors:  J T DUFF; G G WRIGHT; A YARINSKY
Journal:  J Bacteriol       Date:  1956-10       Impact factor: 3.490

4.  Perspectives concerning botulism.

Authors:  K F MEYER; B EDDIE
Journal:  Z Hyg Infektionskr       Date:  1951

5.  Molecular construction of Clostridium botulinum type F progenitor toxin.

Authors:  I Ohishi; G Sakaguchi
Journal:  Appl Microbiol       Date:  1975-04

6.  Oral toxicities of Clostridium botulinum type E toxins of different forms.

Authors:  G Sakaguchi; S Sakaguchi
Journal:  Jpn J Med Sci Biol       Date:  1974-08

7.  Botulinal toxins and the problem of nomenclature of simple toxins.

Authors:  C Lamanna; G Sakaguchi
Journal:  Bacteriol Rev       Date:  1971-09

8.  Purification and some properties of progenitor toxins of Clostridium botulinum type B.

Authors:  S Kozaki; S Sakaguchi; G Sakaguchi
Journal:  Infect Immun       Date:  1974-10       Impact factor: 3.441

9.  Molecular construction of Clostridium botulinum type A toxins.

Authors:  S Sugii; G Sakaguchi
Journal:  Infect Immun       Date:  1975-12       Impact factor: 3.441

10.  Purification of Clostridium botuliunum type F progenitor toxin.

Authors:  I Oishi; G Sakaguchi
Journal:  Appl Microbiol       Date:  1974-12
View more
  43 in total

1.  Cloning and complete nucleotide sequence of the gene for the main component of hemagglutinin produced by Clostridium botulinum type C.

Authors:  K Tsuzuki; K Kimura; N Fujii; N Yokosawa; T Indoh; T Murakami; K Oguma
Journal:  Infect Immun       Date:  1990-10       Impact factor: 3.441

2.  The botulinum toxin complex meets E-cadherin on the way to its destination.

Authors:  Yo Sugawara; Yukako Fujinaga
Journal:  Cell Adh Migr       Date:  2011-01-01       Impact factor: 3.405

3.  Inhibiting oral intoxication of botulinum neurotoxin A complex by carbohydrate receptor mimics.

Authors:  Kwangkook Lee; Kwok-Ho Lam; Anna-Magdalena Kruel; Stefan Mahrhold; Kay Perry; Luisa W Cheng; Andreas Rummel; Rongsheng Jin
Journal:  Toxicon       Date:  2015-08-10       Impact factor: 3.033

4.  Clostridium botulinum types A, B, C1, and E produce proteins with or without hemagglutinating activity: do they share common amino acid sequences and genes?

Authors:  E Somers; B R DasGupta
Journal:  J Protein Chem       Date:  1991-08

Review 5.  Toxigenic clostridia.

Authors:  C L Hatheway
Journal:  Clin Microbiol Rev       Date:  1990-01       Impact factor: 26.132

6.  Pure botulinum neurotoxin is absorbed from the stomach and small intestine and produces peripheral neuromuscular blockade.

Authors:  A B Maksymowych; M Reinhard; C J Malizio; M C Goodnough; E A Johnson; L L Simpson
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

7.  Intestinal absorption of botulinum toxins of different molecular sizes in rats.

Authors:  S Sugii; I Ohishi; G Sakaguchi
Journal:  Infect Immun       Date:  1977-09       Impact factor: 3.441

8.  Biophysical characterization of the stability of the 150-kilodalton botulinum toxin, the nontoxic component, and the 900-kilodalton botulinum toxin complex species.

Authors:  F Chen; G M Kuziemko; R C Stevens
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

9.  Characterization of new formalin-detoxified botulinum neurotoxin toxoids.

Authors:  James E Keller
Journal:  Clin Vaccine Immunol       Date:  2008-07-30

10.  Botulinum hemagglutinin disrupts the intercellular epithelial barrier by directly binding E-cadherin.

Authors:  Yo Sugawara; Takuhiro Matsumura; Yuki Takegahara; Yingji Jin; Yoshikazu Tsukasaki; Masatoshi Takeichi; Yukako Fujinaga
Journal:  J Cell Biol       Date:  2010-05-10       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.